Stock Taper
| DATE | TYPE | RATIO |
|---|---|---|
| 2022-08-19 | Reverse | 1:3 |
| 2020-01-06 | Reverse | 1:8 |
Vivani Medical, Inc. is a clinical-stage company in Emeryville, CA, developing miniature drug implants for chronic diseases and implantable visual prostheses to restore vision in blind individuals.

Vivani Medical's lead product is a miniature, subdermal implant delivering semaglutide for at least six months to treat chronic weight management, with clinical development expected to start in 2026.
Overall rating: D+
| PEER | PRICE | |
|---|---|---|
RCEL | $10.35 | COMPARE |
CRDL | $1.94 | COMPARE |
ORMP | $5.03 | COMPARE |
HYPR | $0.83 | COMPARE |
MBOT | $1.48 | COMPARE |
IMA | $5.34 | COMPARE |
NSPR | $0.85 | COMPARE |